Wild blueberries may have CV benefit; study

12 May 2009

New research, published in the Journal of Medicinal Food and the Journal of Nutritional Biochemistry, shows that wild blueberries may have a  cardio-protective effect, improving vascular function and decreasing the  vulnerability of blood vessels to oxidative stress.

The studies contribute to a growing body of research supporting the  potential protective effect of wild blueberries in the diet on cellular  signaling within the vascular environment. These findings suggest that  the consumption of the fruit could help regulate blood pressure and  combat atherosclerosis.

"Our studies confirm our hypothesis that wild blueberry-enriched diets  significantly diminish arterial constriction in animal models by  relaxing blood vessels, which may have implications on blood pressure  regulation in both animal models with normal blood pressure and ones  with high blood pressure," said lead researcher Dorothy Klimis-Zacas  from the Department of Food Science and Human Nutrition at the US  University of Maine. "The end result is to aid in maintenance of a  functional endothelium which may help prevent vascular complications  associated with hypertension," she added.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight